Curaleaf Holdings’s takeover bid for its Canadian rival Aurora Cannabis has evolved into a public spat between the two cannabis giants over whose financial projections are honest, who would actually control the proposed new entity, and whether the current bid can even close on its own terms.
Spain’s medicines agency has published the first official guidance for medical cannabis preparations, confirming that its incoming market will exclude raw cannabis flower in favour of ‘standardised’ oral solutions prepared exclusively in hospital pharmacies.
Curaleaf International is already one of the most prominent cannabis companies in the world, with a presence in the UK, Germany, France, Italy, Switzerland, Spain, Portugal, Poland and the Czech Republic.
